Long-acting HIV prevention meds: 10 Breakthrough Technologies 2025 - WHO
Gilead Sciences, GSK, ViiV Healthcare
WHEN
1 to 3 years
In June 2024,... - https://www.technologyreview.com/2025/01/03/1108815/long-acting-hiv-prevention-meds-lenacapavir-breakthrough-technologies-2025/ #biotechnologyandhealth #tr102025 #biotech #app